⌘K

Login Start Free

Home/Filings/4/0001415889-25-022468

4//SEC Filing

See Tai Sandi 4

Accession 0001415889-25-022468

CIK 0001907108other

View on SEC.gov Company Profile

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 4:58 PM ET

Size

5.0 KB

Accession

0001415889-25-022468

Insider Transaction Report

Form 4

Period: 2025-08-18

Lexeo Therapeutics, Inc.LXEO

Chief Development Officer

Transactions

Sale
Common Stock
2025-08-18$4.67/sh−382$1,783→ 58,860 total

Footnotes (2)

[F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
[F2]Includes 49,138 RSUs.

Documents

1 file

4
form4-08202025_080818.xmlPrimary

Issuer

Lexeo Therapeutics, Inc.

CIK 0001907108

Entity typeother

Related Parties

1

filerCIK 0002009350

Filing Metadata

Form type: 4
Filed: Aug 19, 8:00 PM ET
Accepted: Aug 20, 4:58 PM ET
Size: 5.0 KB

View on SEC.gov